Scrip Regulatory Affairs
Proposed new feature in future EU IVD Regulation: the classification rules
22 February 2012
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- EU parliament resolution plan expected to call for device pre-market authorisation system
- Commission clarifies IVD classification and borderline issues in revised EU guideline
- EU medtech regulatory reform could involve unannounced notified body visits, greater transparency and tighter controls on Class III devices
- 11 EU medtech notified bodies sign up to voluntary code of conduct
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
